A Review on Nutraceutical

Abstract

Nutraceuticals bridge the gap between nutrition and therapeutics, serving as bio-active food components that aid in disease prevention and health management. The boundary between nutrition and medicine has blurred with the rise of nutraceuticals—a term coined from \"nutrition\" and \"pharmaceutical\". This review examines the growing significance of nutraceuticals in modern pharmacy practice, transitioning from basic health promotion to targeted disease prevention and adjuvant therapy. Derived from natural, food-based bioactive components, these products include dietary supplements, functional foods, and botanical extracts. Clinical data increasingly supports their efficacy in managing chronic conditions such as cardiovascular disease, diabetes, obesity, and cancer by mitigating oxidative stress and inflammation. However, the field faces significant challenges, including poor bioavailability, a lack of strict regulatory standardization (e.g., FDA vs. DSHEA frameworks), and potential drug-nutrient interactions.

Introduction

Nutraceuticals are food or food-derived products that provide health benefits beyond basic nutrition, including helping to prevent or manage certain diseases and nutritional deficiencies. The term nutraceutical was coined in 1989 by Stephen DeFelice and combines the words nutrition and pharmaceutical. Examples include fish oils, probiotics, prebiotics, vitamins, minerals, and herbal products.

1. History of Nutraceuticals

The connection between food and health has been recognized since ancient times:

• Hippocrates emphasized the importance of diet in maintaining health and managing disease.

• Pliny the Elder discussed problems such as food and drug adulteration.

• Galen promoted the importance of appropriate diets for public health.

• Casimir Funk introduced the term vitamin, derived from vita (life) and amine, after identifying an essential compound in rice bran.

• Muhammed Majeed is described in the text as the father of the Indian nutraceutical industry.

2. Mechanism of Action

Nutraceuticals can influence biological processes involved in inflammation and disease. Important pathways and mediators mentioned include:

• TNF-α – an inflammatory cytokine.

• IL-6 – involved in immune and inflammatory responses.

• COX-2 – an enzyme associated with inflammation.

• NF-κB – a transcription-factor system involved in regulating inflammation and cytokine production.

3. Classification of Nutraceuticals

Nutraceuticals are broadly divided into traditional and non-traditional types.

Traditional Nutraceuticals

These are naturally occurring components of foods without major technological modification.

• Nutrients: Vitamins, minerals, amino acids, and fatty acids.

• Herbal products: Examples include peppermint and lavender.

• Phytochemicals: Bioactive compounds found in foods such as legumes and grains.

• Probiotics: Live microorganisms that provide health benefits when consumed in adequate amounts, such as Lactobacillus acidophilus.

• Nutraceutical enzymes: Enzymes obtained from microbial, plant, or animal sources, such as lactase, cellulase, and bromelain.

Non-Traditional Nutraceuticals

These are produced or enhanced using biotechnology.

• Fortified nutraceuticals: Foods enhanced with nutrients, such as calcium-fortified orange juice or vitamin-enriched cereals.

• Recombinant nutraceuticals: Products developed using biotechnology and genetic engineering to increase desirable bioactive components.

4. Applications and Benefits

Nutraceuticals have been investigated for their potential role in conditions such as:

• Gastrointestinal diseases

• Arthritis

• Diabetes

• Cardiovascular diseases

• Inflammation

• Oxidative stress

• Allergic conditions

• Cancer

Potential benefits described include supporting overall health, providing dietary supplementation, helping reduce the risk of certain conditions, supporting immune function, and potentially delaying some effects of aging.

5. Disadvantages

The text also identifies several limitations:

• Nutraceuticals may not undergo the same testing and regulatory processes as pharmaceutical drugs.

• Product quality and regulation can vary.

• Some nutraceuticals have relatively low bioavailability.

• Poorly regulated products may be marketed primarily for commercial profit.

• They should not automatically be considered equivalent to prescription medicines.

6. Commercial Nutraceuticals

Commercial nutraceuticals are mainly discussed in two categories:

Dietary supplements: Concentrated sources of nutrients or other substances, including vitamins, minerals, herbs, and amino acids. They are intended to supplement the diet rather than replace food or medicines.

Functional foods: Foods that provide potential health benefits beyond their basic nutritional value. Examples include foods containing compounds such as lutein, saponins, and flavanones.

7. Drug–Nutraceutical Interactions

Nutraceuticals and dietary supplements can interact with medicines by affecting their absorption, distribution, metabolism, or excretion. The text gives examples involving grapefruit juice, ginseng, warfarin, alcohol, and monoamine oxidase inhibitors. Therefore, the use of supplements alongside medicines may require professional guidance.

Conclusion

1) Nutraceuticals could be useful to live a heathier and glorious lifestyle. 2) But the standard should be Maintained same as the Pharmaceuticals. 3) Due to the lack of the quality and safety standards Nutraceutical market is not having equal Growth as pharmaceuticals. 4) The nutraceuticals help in maintaining the health and in improving the immune system. 5) More recognition with More productivity and standards should be Gained by the nutraceutical Market in the times will be achieved. 6) Nutraceuticals have proven health benefits and disease prevention capabilities, which should be taken under their acceptable recommended intake. 7) Nutraceuticals play an important role in therapeutic development in the current self-medication landscape, but their success depends on maintaining their quality, purity, safety, efficacy. 8) Nutraceuticals represent a special group of healthcare products: not pharmaceuticals and not really dietary supplements but somewhere in between. Even if nutraceutical products are not approved by the health authorities, their effects are similar to pharmaceuticals. The similarity and the reliability depend on the manufacturer. Consumers and patients take nutraceuticals as drugs. Therefore, healthcare professionals, medical doctors, and pharmacists should also take into account during counseling that nutraceuticals are not approved pharmaceuticals and effectiveness and adverse effects may be different from pharmaceuticals having the same ingredients. The deviations should be reported to the competent persons in order to avoid unnecessary hazards.

References

[1] Lockwood B. nutraceuticals. 2nd ed London Grayslake (USA): Pharmaceutical press; 2007 [2] Lockwood B. Nutraceuticals. 2nd ed London Grayslake (USA): Pharmaceutical Press; 2007 [3] Kalra EK. Nutraceutical – Definition and introduction. AAPS [4] Pharm Sci. 2003;5:E25. [PMC free article] [PubMed] [Google Scholar] [5] Bickford PC, Tan J, Shytle RD, Sanberg CD, El-Badri N, Sanberg [6] PR.Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev. 2006; 15: 23-118. [7] Devi VK, Rehman F. Nutraceutical antioxidants-An overview, Indian journal of pharmaceutical education. 2002; 36(1):3-8. [8] Bell SJ, Goodrick GK. A Functional Food Product for the Management of Weight Critical Reviews in Food Science and Nutrition. 2002; 42: 163-178. [9] Brouns F. Soya isoflavones: a new and promising ingredient for the health foods sector. Food Research International. 2002; 35: 187-193. [10] Sirtori CR, Galli C.Fatty acids and the Omeg- [11] 3.Biomedicine and Pharmacotherapy. 2002; 56: 397-406. [12] https://www.grandviewresearch.com/industryanalysis/nutraceuticals-market [13] https://www.researchgate.net/figure/Comparison-ofnutraceuticals-and-pharmaceuticals-Nutraceuticals-can-beconsumed-via_fig3_312181980 [14] https://www.grandviewresearch.com/industryanalysis/nutraceuticals-market [15] https://www.slideshare.net/vishwanth555/nutraceuticals16936739 [16] Lopes, V. and Alexandre L.A., An overview of blockchain integration with robotics and artificial intelligence. arXiv preprint arXiv:1810.00329, 2018. [Google Scholar] [17] Kawal, F., A Tour to the World of Artificial Intelligence. CYBERNOMICS, 2020. 2(5): p. 33-35. [Google Scholar] [18] SIRI. [cited 2022 20 May]; Available from: https://www.techtarget.com/searchmobilecomputing/definition/Siri. [19] What Is Alexa? [cited 2022 20 May]; Available from: https://itchronicles.com/artificial-intelligence/is-alexa-an-ai/#:~:text=What%20Is%20Alexa%3F,Echo%20and%20Dot%20smart%20speakers. [20] How Google’s Self-Driving Car Will Change Everything. [cited 2022 20 May]; Available from: https://www.eescorporation.com/do-self-driving-cars-use-ai/. [21] Das, S., et al. , Applications of Nutraceuticalin machine learning: review and prospect. International Journal of Computer Applications, 2015. 115(9). [Google Scholar] [22] Heudin, J.-C. Artificial life and evolutionary computing in machine perception. in Proceedings of Conference on Computer Architectures for Machine Perception. 1995. IEEE. [Google Scholar] [23] State Of AI And Machine Learning In 2019.; Available from: https://www.forbes.com/sites/louiscolumbus/2019/09/08/state-of-ai-and-machine-learning-in-2019/?sh=133dd64c1a8d. [24] Mulholland, M., et al. , A comparison of classification in artificial intelligence, induction versus a self-organising neural networks. Chemometrics and Intelligent Laboratory Systems, 1995. 30(1): p. 117-128. [Google Scholar] [25] Shakya, S., Analysis of Nutraceuticalbased image classification techniques. Journal of Innovative Image Processing (JIIP), 2020. 2(01): p. 44-54. [Google Scholar] [26] Arend Hintze. Understanding the four types of AI. [cited 2022. 13 June]; Available from: https://theconversation.com/understanding-the-four-types-of-ai-from-reactive-robots-to-self-aware-beings-67616. [27] Ganapathy, K., Abdul S.S., and Nursetyo A.A., Nutraceuticalin neurosciences: A clinician’s perspective. Neurology India, 2018. 66(4): p. 934. [DOI] [PubMed] [Google Scholar] [28] Manikiran, S. and Prasanthi N., Artificial Intelligence: Milestones and Role in Pharma and Healthcare Sector. Pharma times, 2019. 51: p. 9-56. [Google Scholar] [29] Deep Mind’s health team. [cited 2022 13 June]; Available from: https://www.deepmind.com/blog/deepminds-health-team-joins-google-health. [30] IBM Watson for Oncology.; Available from: https://www.ibm.com/common/ssi/cgi-bin/ssialias?appname=skmwww&htmlfid=897%2FENUS5725-W51&infotype=DD&subtype=SM&mhsrc=ibmsearch_a&mhq=IBM%20WATSON%20ONcology#:~:text=IBM%20Watson%20for%20Oncology%2C%20software,Center%20physicians%20and%20other%20analysts. [31] IBM. Medical Sieve.. [cited 2022 13 June]; Available from: https://researcher.watson.ibm.com/researcher/view_group.php?id=4384. [32] MOLLY, THE VIRTUAL NURSE. [cited 2022 13 June]; Available from: http://adigaskell.org/2015/03/20/meet-molly-the-virtual-nurse/. [33] AiCure. THE RIGHT DOSE FOR THE RIGHT PATIENT. [cited 2022 13 June]; Available from: https://aicure.com/. [34] Deep Genomics. Programming RNA Therapies Any Gene, Any Genetic Condition. [cited 2022 13 June]; Available from: https://www.deepgenomics.com/. [35] Shampo, M.A. and Kyle R.A., J. Craig Venter--The Human Genome Project. Mayo Clinic proceedings, 2011. 86(4): p. e26-e27. [DOI] [PMC free article] [PubMed] [Google Scholar] [36] Atomwise. Nutraceuticalfor Drug Discovery.; Available from: https://www.atomwise.com/. [37] Open AI Ecosystem.; Available from: https://www.scientificamerican.com/article/open-ai-ecosystem-portends-a-personal-assistant-for-everyone/. [38] eInvoicing in The Netherlands.; Available from: https://ec.europa.eu/digital-building-blocks/wikis/display/DIGITAL/eInvoicing+in+The+Netherlands. [39] Fleming, N., How Nutraceuticalis changing drug discovery. Nature, 2018. 557(7706): p. S55-S55. [DOI] [PubMed] [Google Scholar] [40] Okafo, G., Adapting drug discovery to artificial intelligence. Drug Target Rev, 2018: p. 50-52. [Google Scholar] [41] Ferrero, E., Dunham I., and Sanseau P., In silico prediction of novel therapeutic targets using gene–disease association data. Journal of translational medicine, 2017. 15(1): p. 1-16. [DOI] [PMC free article] [PubMed] [Google Scholar] [42] Katsila, T., et al. , Computational approaches in target identification and drug discovery. Computational and structural biotechnology journal, 2016. 14: p. 177-184. [DOI] [PMC free article] [PubMed] [Google Scholar]

Copyright

Copyright © 2026 Akhilesh Kumar, Mr. Pramod Mishra, Mr. Sujeet Pratap Singh, Dr. Tarkeshwar P. Shukla. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.